Suppr超能文献

是否最好使用两种弹性成像方法来评估肝纤维化?

Is it better to use two elastographic methods for liver fibrosis assessment?

机构信息

Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy Timişoara, 10 Iosif Bulbuca Bv. 300736 Timisoara, Romania.

出版信息

World J Gastroenterol. 2011 Sep 7;17(33):3824-9. doi: 10.3748/wjg.v17.i33.3824.

Abstract

AIM

To find out if by combining 2 ultrasound based elastographic methods: acoustic radiation force impulse (ARFI) elastography and transient elastography (TE), we can improve the prediction of fibrosis in patients with chronic hepatitis C.

METHODS

Our study included 197 patients with chronic hepatitis C. In each patient, we performed, in the same session, liver stiffness (LS) measurements by means of TE and ARFI, respectively, and liver biopsy (LB), assessed according to the Metavir score. 10 LS measurements were performed both by TE and ARFI; median values were calculated and expressed in kilopascals (kPa) and meters/second (m/s), respectively. Only TE and ARFI measurements with IQR < 30% and SR ≥ 60% were considered reliable.

RESULTS

On LB 13 (6.6%) patients had F0, 32 (16.2%) had F1, 52 (26.4%) had F2, 47 (23.9%) had F3, and 53 (26.9%) had F4. A direct, strong correlation was found between TE measurements and fibrosis (r = 0.741), between ARFI and fibrosis (r = 0.730) and also between TE and ARFI (r = 0.675). For predicting significant fibrosis (F ≥ 2), for a cut-off of 6.7 kPa, TE had 77.5% sensitivity (Se) and 86.5% specificity (Sp) [area under the receiver operating characteristic curve (AUROC) 0.87] and for a cut-off of 1.2 m/s, ARFI had 76.9% Se and 86.7% Sp (AUROC 0.84). For predicting cirrhosis (F = 4), for a cut-off of 12.2 kPa, TE had 96.2% Se and 89.6% Sp (AUROC 0.97) and for a cut-off of 1.8 m/s, ARFI had 90.4% Se and 85.6% Sp (AUROC 0.91). When both elastographic methods were taken into consideration, for predicting significant fibrosis (F ≥ 2), (TE ≥ 6.7 kPa and ARFI ≥ 1.2 m/s) we obtained 60.5% Se, 93.3% Sp, 96.8% positive predictive value (PPV), 41.4% negative predictive value (NPV) and 68% accuracy, while for predicting cirrhosis (TE ≥ 12.2 kPa and ARFI ≥ 1.8 m/s) we obtained 84.9% Se, 94.4% Sp, 84.9% PPV, 94.4% NPV and 91.8% accuracy.

CONCLUSION

TE used in combination with ARFI is highly specific for predicting significant fibrosis; therefore when the two methods are concordant, liver biopsy can be avoided.

摘要

目的

探讨联合应用两种基于超声的弹性成像技术:声辐射力脉冲(ARFI)弹性成像和瞬时弹性成像(TE)是否能提高对慢性丙型肝炎患者纤维化的预测能力。

方法

本研究纳入了 197 例慢性丙型肝炎患者。在同一检查中,分别采用 TE 和 ARFI 进行肝脏硬度(LS)测量,同时进行肝脏活检(LB),并根据 Metavir 评分进行评估。TE 和 ARFI 分别进行了 10 次 LS 测量,计算并分别以千帕(kPa)和米/秒(m/s)表示中位数。仅考虑 IQR<30%和 SR≥60%的 TE 和 ARFI 测量值是可靠的。

结果

LB 显示,13 例(6.6%)患者为 F0,32 例(16.2%)为 F1,52 例(26.4%)为 F2,47 例(23.9%)为 F3,53 例(26.9%)为 F4。TE 测量值与纤维化之间存在直接、强烈的相关性(r=0.741),ARFI 与纤维化之间存在直接、强烈的相关性(r=0.730),TE 与 ARFI 之间也存在直接、强烈的相关性(r=0.675)。对于预测显著纤维化(F≥2),TE 的截断值为 6.7 kPa 时,具有 77.5%的灵敏度(Se)和 86.5%的特异性(Sp)[受试者工作特征曲线(ROC)下面积(AUROC)为 0.87],ARFI 的截断值为 1.2 m/s 时,具有 76.9%的 Se 和 86.7%的 Sp(AUROC 为 0.84)。对于预测肝硬化(F=4),TE 的截断值为 12.2 kPa 时,具有 96.2%的 Se 和 89.6%的 Sp(AUROC 为 0.97),ARFI 的截断值为 1.8 m/s 时,具有 90.4%的 Se 和 85.6%的 Sp(AUROC 为 0.91)。当同时考虑两种弹性成像方法时,对于预测显著纤维化(F≥2)(TE≥6.7 kPa 和 ARFI≥1.2 m/s),我们获得了 60.5%的 Se、93.3%的 Sp、96.8%的阳性预测值(PPV)、41.4%的阴性预测值(NPV)和 68%的准确率;对于预测肝硬化(TE≥12.2 kPa 和 ARFI≥1.8 m/s),我们获得了 84.9%的 Se、94.4%的 Sp、84.9%的 PPV、94.4%的 NPV 和 91.8%的准确率。

结论

TE 联合 ARFI 对预测显著纤维化具有高度特异性;因此,当两种方法一致时,可以避免进行肝脏活检。

相似文献

1
Is it better to use two elastographic methods for liver fibrosis assessment?
World J Gastroenterol. 2011 Sep 7;17(33):3824-9. doi: 10.3748/wjg.v17.i33.3824.
8
Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
Scand J Gastroenterol. 2014 Aug;49(8):986-92. doi: 10.3109/00365521.2014.909528. Epub 2014 Apr 17.

引用本文的文献

2
Current status of imaging in nonalcoholic fatty liver disease.
World J Hepatol. 2018 Aug 27;10(8):530-542. doi: 10.4254/wjh.v10.i8.530.
4
Current role of transient elastography in the management of chronic hepatitis B patients.
Ultrasonography. 2017 Apr;36(2):86-94. doi: 10.14366/usg.16023. Epub 2016 Oct 26.
7
Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.
World J Gastroenterol. 2015 Apr 21;21(15):4432-9. doi: 10.3748/wjg.v21.i15.4432.
8
Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.
World J Gastroenterol. 2014 Jun 28;20(24):7718-29. doi: 10.3748/wjg.v20.i24.7718.
9
Liver elastography, comments on EFSUMB elastography guidelines 2013.
World J Gastroenterol. 2013 Oct 14;19(38):6329-47. doi: 10.3748/wjg.v19.i38.6329.

本文引用的文献

2
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
J Hepatol. 2010 Feb;52(2):191-8. doi: 10.1016/j.jhep.2009.11.008. Epub 2009 Nov 24.
3
Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
J Viral Hepat. 2010 Aug;17(8):546-54. doi: 10.1111/j.1365-2893.2009.01210.x. Epub 2009 Oct 27.
4
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.
Ultraschall Med. 2009 Oct;30(5):478-84. doi: 10.1055/s-0028-1109488. Epub 2009 Oct 7.
8
Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.
Gastroenterology. 2008 Apr;134(4):960-74. doi: 10.1053/j.gastro.2008.01.034. Epub 2008 Jan 18.
9
Assessment of hepatic fibrosis with magnetic resonance elastography.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1207-1213.e2. doi: 10.1016/j.cgh.2007.06.012.
10
FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.
Am J Gastroenterol. 2007 Nov;102(11):2589-600. doi: 10.1111/j.1572-0241.2007.01466.x. Epub 2007 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验